Comments
Loading...
Metagenomi (MGX) Forecast
NewsEarningsMetagenomi (MGX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMetagenomi (NASDAQ:MGX) Stock Quotes, Forecast and News Summary
Metagenomi Stock (NASDAQ: MGX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Metagenomi (MGX) stock?
You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.
Who are Metagenomi (MGX) competitors?
Other companies in Metagenomi’s space includes: Kezar Life Sciences (NASDAQ:KZR), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB) and Connect Biopharma Hldgs (NASDAQ:CNTB).
What is the forecast, or price target, for Metagenomi (MGX) stock?
Metagenomi has a consensus price target of $15.50.
What is the current price for Metagenomi (MGX)?
The stock price for Metagenomi (NASDAQ: MGX) is $1.7185 last updated November 21, 2024 at 10:38 AM EST.
Does Metagenomi (MGX) pay a dividend?
There are no upcoming dividends for Metagenomi.
When is Metagenomi (NASDAQ:MGX) reporting earnings?
Metagenomi’s Q4 earnings are confirmed for Wednesday, February 12, 2025.
Is Metagenomi (MGX) going to split?
There is no upcoming split for Metagenomi.
What sector and industry does Metagenomi (MGX) operate in?
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.